Cannabics Pharmaceuticals, Inc.
(Other OTC/NBB : CNBX)

( )
CNBX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-1.08%278.821.4%$741.23m
AMGNAmgen, Inc.
-0.74%203.321.3%$386.61m
CELGCelgene Corp.
0.28%104.991.3%$376.93m
GILDGilead Sciences, Inc.
1.09%66.581.0%$375.52m
ILMNIllumina, Inc.
1.15%312.593.5%$232.71m
VRTXVertex Pharmaceuticals, Inc.
-0.29%190.511.9%$216.99m
REGNRegeneron Pharmaceuticals, Inc.
1.23%305.022.6%$210.35m
ALXNAlexion Pharmaceuticals, Inc.
7.40%106.631.9%$181.77m
EXASEXACT Sciences Corp.
-1.52%87.5024.0%$173.24m
AAgilent Technologies, Inc.
0.38%74.971.6%$132.59m
SGENSeattle Genetics, Inc.
1.34%99.966.2%$132.30m
SRPTSarepta Therapeutics, Inc.
-1.67%84.1214.6%$125.03m
BMRNBioMarin Pharmaceutical, Inc.
1.89%69.014.3%$96.83m
ALDRAlder Biopharmaceuticals, Inc.
-0.21%18.8810.2%$94.86m
NKTRNektar Therapeutics
-2.50%16.775.5%$80.05m

Company Profile

Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.